Schedule 13G ownership disclosure

MERSANA THERAPEUTICS INC

Security class unavailable · CUSIP: 59045L106

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
818,033
Percent of class
3.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001171520-18-000071
Form type
SC 13G
Filer
Mersana Therapeutics, Inc.
CIK
CIK 1442836
Filed
Feb 09, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub